Abstract:Objective To detect the levels of peptidylarginine deiminase 4 (PAD4) mRNA and neutrophil extracellular traps (NETs) of the peripheral blood neutrophils in rheumatoid arthritis (RA) patients and to study the association between PAD4 and NETs in RA.The anti-cyclic citrullinated peptide (anti CCP) antibodies,disease activity score (DAS28) score,erythrocyte sedimentation rate (ESR) were recorded.Its value in the pathogenesis of RA was explored.T test,rank-sum test,Pearson and Spearman correlative analysis were used for statical analysis.Methods The serum double-stranded DNA (dsDNA)/NETs in 43 RA patients and 20 healthy controls were detected by PicoGreen dsDNA Quantitation Kits (Invitrogen).Real-time quantitative polymerase chain reaction (RT-PCR) was used to determine the expression of PAD4 mRNA in neutrophils,and the relationship between dsDNA/NETs and their clinical indexes were analyzed.Results ① The level of peripheral blood neutrophils PAD4 mRNA in RA was significantly higher than healthy controls [1.493(0.831,2.607)] vs [0.631(0.358,1.489)],(Z=-2.07,P=0.039).The levels of serum PAD4 mRNA in RA treated with disease-modifying antirheumatic drugs (DMARDs) were lower than untreated with DMARDs but no significant difference was found (Z=-1.19,P=0.234).② The levels of serum dsDNA/NETs in RA patients were significantly higher than in healthy controls (t=3.4,P=0.001).③ The levels of serum dsDNA/NETs in RA were positively correlated with DAS28 score,ESR,CRP and PAD4 mRNA (r=0.36,P=0.036;r=0.345,P=0.042;r=0.36,P=0.043;r=0.42,P=0.017) but not with anti-CCP antibodies (r=0.277,P=0.154).Conclusion ① PAD4 may play an important role in the pathogenesis of RA.② NETs maybe associated with disease activity and play an important role in RA pathogenesis,inhibit NETs generation or improve the ability to clear NETs,perhaps can treat RA.③ PAD4 probably play an important role in rheumatoid arthritis by influencing the formation of the NETs.

Peptidylarginine deiminases 4 as a promising target in drug discovery

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis

Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment

Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4

Phosphodiesterase-4(PDE4) As a Target for Anti-Inflammatory Drug Discovery: Present and Prospect

PAD4 and Its Inhibitors in Cancer Progression and Prognosis

Structure–Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy

Progress in PDE4 Targeted Therapy for Inflammatory Diseases

Screening and identification of peptidyl arginine deiminase 4 inhibitors from herbal plants extracts and purified natural products by a trypsin assisted sensitive immunoassay based on streptavidin magnetic beads

Alleviation of arthritis through prevention of neutrophil extracellular traps by an orally available inhibitor of protein arginine deiminase 4

PADs in cancer: Current and future

Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.

Identification of novel PAD4 inhibitors using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulations

Identification of Novel PAD4 Inhibitors Based on a Pharmacophore Model Derived from Transition State Coordinates.

Modes of PADing

Discover Natural Compounds As Potential Phosphodiesterase-4B Inhibitors Via Computational Approaches

Screening of peptidyl arginine deiminase 4 inhibitors in traditional herbal medicines

Role of Peptidylarginine Deiminase 4 in Central Nervous System Diseases

Peptidylarginine Deiminase 4 Probably Play an Important Role in Rheumatoid Arthritis by Involving in the Formation of the Neutrophil Extracellular Traps

Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment

Role of protein deimination in cardiovascular diseases: potential new avenues for diagnostic and prognostic biomarkers